Shock, Septic

• 

  Subject Areas on Research

  • A Rare Case of Isolated Congenital Asplenia Presenting in Septic Shock: Howell-Jolly Bodies a Clue to Early Diagnosis. 
  • A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. 
  • A multibiomarker-based outcome risk stratification model for adult septic shock*. 
  • A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. 
  • A randomized trial of protocol-based care for early septic shock. 
  • Accuracy of microscopic urine analysis and chest radiography in patients with severe sepsis and septic shock. 
  • Altered mitochondrial redox responses in gram negative septic shock in primates. 
  • American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. 
  • Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock. 
  • Block-diagonal discriminant analysis and its bias-corrected rules. 
  • Calcium/calmodulin-dependent protein kinase kinase 2 regulates macrophage-mediated inflammatory responses. 
  • Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system. 
  • Challenges and Opportunities for Emergency Department Sepsis Screening at Triage. 
  • Characterization of cardiac dysfunction in sepsis: an ongoing challenge. 
  • Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial. 
  • Clostridial infection of a liver transplant treated with retransplantation. 
  • Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids. 
  • Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock. 
  • Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. 
  • Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. 
  • Developing a clinically feasible personalized medicine approach to pediatric septic shock. 
  • Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. 
  • Disseminated Mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient. 
  • Dopamine and dobutamine in septic shock. A comparison. 
  • Drotrecogin alfa (activated) in adults with septic shock. 
  • Dynamin-related Irgm proteins modulate LPS-induced caspase-11 activation and septic shock. 
  • Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis. 
  • Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. 
  • Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap? 
  • Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response. 
  • Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. 
  • Escherichia coli septic shock following colonic hydrotherapy. 
  • Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. 
  • Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy. 
  • External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients. 
  • Extracorporeal Membrane Oxygenation for Hemodynamic Support. 
  • Extracorporeal membrane oxygenation for neonatal and pediatric respiratory failure: an evidence-based review of the past decade (2002-2012). 
  • Fluid Resuscitation in Septic Patients With Comorbid Heart Failure. 
  • Globin attenuates the innate immune response to endotoxin. 
  • Glucocorticoid therapy in sepsis/shock caused by gram-negative microorganisms. 
  • Glutamine and heat shock protein expression. 
  • Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. 
  • Glutamine induces heat shock protein and protects against endotoxin shock in the rat. 
  • Gram-negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non-transplant recipients. 
  • Gram-negative sepsis and endotoxic shock (lecture). 
  • Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia. 
  • Images in Anesthesiology: Examining the Edges of Extravasation. 
  • Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. 
  • Index of suspicion. 
  • Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. 
  • Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study. 
  • Interleukin-1 receptor-associated kinase-1: more evidence. 
  • Is vasopressin an ideal vasopressor to treat hypotension in septic shock? 
  • Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? 
  • Kilohertz frequency nerve block enhances anti-inflammatory effects of vagus nerve stimulation. 
  • Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. 
  • Macro- and Microvascular Parameters After Toxic Shock Syndrome. 
  • Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial. 
  • Myocardial adenosine triphosphate levels during early sepsis. 
  • Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. 
  • Nucleic acid-binding polymers as anti-inflammatory agents. 
  • Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype. 
  • Photoperiodic adjustments in immune function protect Siberian hamsters from lethal endotoxemia. 
  • Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. 
  • Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis. 
  • Predictors of Vasopressin Responsiveness in Critically Ill Adults. 
  • Predictors of patients who present to the emergency department with sepsis and progress to septic shock between 4 and 48 hours of emergency department arrival. 
  • Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology. 
  • Protection from death in endotoxin shock: does fish oil need a LIF? 
  • Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan. 
  • Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88. 
  • Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes. 
  • Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment. 
  • Sepsis Subclasses: A Framework for Development and Interpretation. 
  • Simplification of a Septic Shock Endotyping Strategy for Clinical Application. 
  • Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study. 
  • Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype. 
  • Stunned myocardium in the toxic shock syndrome. 
  • Sudden infant death syndrome: a toxic response. 
  • Systemic loxoscelism in a nonendemic area: a diagnostic challenge for the unsuspecting physician. 
  • Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. 
  • The American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: Executive Summary. 
  • The Dose Makes the Poison: Comparing Epinephrine With Dopamine in Pediatric Septic Shock. 
  • The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock. 
  • The GENESIS project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. 
  • The changing pattern of bacterial sepsis since the introduction of antibiotic therapy. 
  • The temporal version of the pediatric sepsis biomarker risk model. 
  • The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature. 
  • Thrombocytopenia in hospitalized patients with severe clostridium difficile infection. 
  • Toxic shock syndrome after inguinal hernia repair. Report of a case with patient survival. 
  • Toxic strep syndrome. 
  • Treatment of anemia with darbepoetin alfa in systolic heart failure. 
  • Urologic sepsis/shock. 
  • VA/Q abnormalities during gram negative sepsis. 
• 

  Keywords of People

  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases